PCSS 2021 MAT Waiver Eligibility Training

The APPD is hosting the PCSS 2021 MAT Waiver Eligibility Training for your fellows. The four-hour live session will be split into two, two-hour sessions on:

• Wednesday, August 18 from 8-10 pm ET
• Wednesday, August 25 from 8-10 pm ET

Register Now!

Participants must attend and fully participate in both sessions to complete the live (in-person or virtual) portion of the training.

Opioid use disorder (OUD) is a challenging clinical conundrum frequently encountered by chronic pain physicians. As a generally safer opioid, buprenorphine provides another tool in the pain physician’s toolbox to treat this vulnerable population for pain and addiction. To treat OUD patients with buprenorphine, one is best served with further education on the topic. For physicians, this has traditionally been an eight-hour training, either all done online or a half/half training, i.e. four hours online and four hours in-person (or virtual).

This virtual course for pain fellows comprises the second half of the relevant training and education to better understand how to prescribe buprenorphine for opioid use disorder. The instructor, Dr. Sudheer Potru, is an assistant professor at the Emory University School of Medicine and a triple-board-certified anesthesiologist, pain physician, and addiction medicine specialist who actively prescribes buprenorphine for both pain and opioid use disorder.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Additional information on PCSS can be found at www.pcssNOW.org. AAAP is the DATA 2000 sponsor for this training. Please contact pcss@aaap.org with any questions regarding this information.